ARTICLE | Company News
GW Pharma sales and marketing update
July 11, 2011 7:00 AM UTC
GW Pharmaceuticals launched Sativex in Germany to treat spasticity due to multiple sclerosis (MS) in patients who are not responding to other therapies. ...
GW Pharmaceuticals launched Sativex in Germany to treat spasticity due to multiple sclerosis (MS) in patients who are not responding to other therapies. ...